Jim Cramer on Merck & Co.: “The Stock’s Starting to Come Back”

Merck & Co., Inc. (NYSE:MRK) was among the stocks on Jim Cramer’s radar on Mad Money. When a caller inquired about the stock during the episode, Cramer said:

Okay, I thought Merck got, you know what, Merck reported a really good quarter, and it just happened on a day when people didn’t like pharma, and they didn’t like healthcare. And Rob Davis did a good job. The stock’s starting to come back. It was up $3 today. I think it can manage its way, all the way back to $120. I think you do good homework.

Image by MayoFi from Pixabay

Merck & Co., Inc. (NYSE:MRK) is a healthcare company that provides a wide range of human and veterinary pharmaceuticals, vaccines, and health solutions. During the April 22 episode, a caller asked if they should switch to another stock or stick to MRK. The Mad Money host responded:

Okay, I’ve gotta tell you, this rotation out of healthcare is one of the most breathtaking rotations. We could be talking about a half dozen drug stocks, and they would all be the same. I think that Merck is at 13 times earnings. I think Merck is terrific. I don’t think that matters at all. I think the stock could drop another five, so you want to buy some and then leave, I like to say leave room. Hey, maybe divide by 10. It’s an $11 stock. Maybe it goes to 10 and a half.

While we acknowledge the risk and potential of MRK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MRK and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.